The involvement of CD146 and its novel ligand galectin-1 in apoptotic regulation of endothelial cells

Journal of Biological Chemistry

Volumn 288, Issue 4, 2013, Pages 2571-2579

  Jouve, Nathalie ^a   Despoix, Nicolas ^a   Espeli, Marion ^b   Gauthier, Laurent ^c   Cypowyj, Sophie ^a   Fallague, Karim ^a   Schiff, Claudine ^b,d   Dignat George, Françoise ^a,e   Vély, Frédéric ^b,d,e   Leroyer, Aurélie S ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INNATE PHARMA   (France)

^d CNRS   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC; BIACORE; CELL APOPTOSIS; CELL SURFACE EXPRESSION; CO-IMMUNOPRECIPITATION EXPERIMENTS; DOSE-DEPENDENT MANNER; DOWN-REGULATION; GALECTIN-1; GLYCOSYLATED; GLYCOSYLATIONS; HUMAN VASCULAR ENDOTHELIAL CELLS; IN-VITRO; JUNCTIONAL ADHESION MOLECULES; N-GLYCANS; NOVEL LIGANDS; VASCULAR CELLS; VESSEL INTEGRITY;

CELL MEMBRANES; ENDOTHELIAL CELLS; LIGANDS;

CELL DEATH;

CD146 ANTIGEN; GALECTIN 1;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; BINDING SITE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; SURFACE PLASMON RESONANCE; UPREGULATION;

ANTIGENS, CD146; APOPTOSIS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GALECTIN 1; GALECTIN 2; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KINETICS; LIGANDS; POLYSACCHARIDES; PROTEIN BINDING; RNA, SMALL INTERFERING; SURFACE PLASMON RESONANCE; TRANSFECTION;

EID: 84873868361     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.418848     Document Type: Article

References (60)

1. Shih, I. M. (1999) The role of CD146 (Mel-CAM) in biology and pathology. J. Pathol. 189, 4-11
2. George, F., Brisson, C., Poncelet, P., Laurent, J. C., Massot, O., Arnoux, D., Ambrosi, P., Klein-Soyer, C., Cazenave, J. P., and Sampol, J. (1992) Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb. Haemost 67, 147-153
3. Aldovini, D., Demichelis, F., Doglioni, C., Di Vizio, D., Galligioni, E., Brugnara, S., Zeni, B., Griso, C., Pegoraro, C., Zannoni, M., Gariboldi, M., Balladore, E., Mezzanzanica, D., Canevari, S., and Barbareschi, M. (2006) M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int. J. Cancer 119, 1920-1926
4. Covas, D. T., Panepucci, R. A., Fontes, A. M., Silva, W. A., Jr., Orellana, M. D., Freitas, M. C., Neder, L., Santos, A. R., Peres, L. C., Jamur, M. C., and Zago, M. A. (2008) Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 36, 642-654
5. Johnson, J. P., Bar-Eli, M., Jansen, B., and Markhof, E. (1997) Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand. Int. J. Cancer 73, 769-774
6. Kristiansen, G., Yu, Y., Schlüns, K., Sers, C., Dietel, M., and Petersen, I. (2003) Expression of the cell adhesion molecule CD146/MCAM in nonsmall cell lung cancer. Anal. Cell. Pathol. 25, 77-81
7. Pickl, W. F., Majdic, O., Fischer, G. F., Petzelbauer, P., Faé, I., Waclavicek, M., Stöckl, J., Scheinecker, C., Vidicki, T., Aschauer, H., Johnson, J. P., and Knapp, W. (1997) MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J. Immunol. 158, 2107-2115
8. Wu, Z., Li, J., Yang, X., Wang, Y., Yu, Y., Ye, J., Xu, C., Qin, W., and Zhang, Z. (2012) MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumour. Biol. 33, 1619-1628
9. Zabouo, G., Imbert, A. M., Jacquemier, J., Finetti, P., Moreau, T., Esterni, B., Birnbaum, D., Bertucci, F., and Chabannon, C. (2009) CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res. 11, R1
10. Anfosso, F., Bardin, N., Francès, V., Vivier, E., Camoin-Jau, L., Sampol, J., and Dignat-George, F. (1998) Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125(FAK). J. Biol. Chem. 273, 26852-26856
11. Bardin, N., Anfosso, F., Massé, J. M., Cramer, E., Sabatier, F., Le Bivic, A., Sampol, J., and Dignat-George, F. (2001) Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98, 3677-3684
12. Bardin, N., Blot-Chabaud, M., Despoix, N., Kebir, A., Harhouri, K., Arsanto, J. P., Espinosa, L., Perrin, P., Robert, S., Vely, F., Sabatier, F., Le Bivic, A., Kaplanski, G., Sampol, J., and Dignat-George, F. (2009) CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 29, 746-753
13. Harhouri, K., Kebir, A., Guillet, B., Foucault-Bertaud, A., Voytenko, S., Piercecchi-Marti, M. D., Berenguer, C., Lamy, E., Vely, F., Pisano, P., Ouafik, L., Sabatier, F., Sampol, J., Bardin, N., Dignat-George, F., and Blot- Chabaud, M. (2010) Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood 115, 3843-3851
14. Kebir, A., Harhouri, K., Guillet, B., Liu, J. W., Foucault-Bertaud, A., Lamy, E., Kaspi, E., Elganfoud, N., Vely, F., Sabatier, F., Sampol, J., Pisano, P., Kruithof, E. K., Bardin, N., Dignat-George, F., and Blot-Chabaud, M. (2010) CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo. Circ. Res. 107, 66-75
15. Solovey, A. N., Gui, L., Chang, L., Enenstein, J., Browne, P. V., and Hebbel, R. P. (2001) Identification and functional assessment of endothelial P1H12. J. Lab. Clin. Med. 138, 322-331
16. Anfosso, F., Bardin, N., Vivier, E., Sabatier, F., Sampol, J., and Dignat- George, F. (2001) Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J. Biol. Chem. 276, 1564-1569
17. Guezguez, B., Vigneron, P., Lamerant, N., Kieda, C., Jaffredo, T., and Dunon, D. (2007) Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J. Immunol. 179, 6673-6685
18. Staquicini, F. I., Tandle, A., Libutti, S. K., Sun, J., Zigler, M., Bar-Eli, M., Aliperti, F., Pérez, E. C., Gershenwald, J. E., Mariano, M., Pasqualini, R., Arap, W., and Lopes, J. D. (2008) A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 68, 8419-8428
19. Flanagan, K., Fitzgerald, K., Baker, J., Regnstrom, K., Gardai, S., Bard, F., Mocci, S., Seto, P., You, M., Larochelle, C., Prat, A., Chow, S., Li, L., Vandevert, C., Zago, W., Lorenzana, C., Nishioka, C., Hoffman, J., Botelho, R., Willits, C., Tanaka, K., Johnston, J., and Yednock, T. (2012) Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS. PLoS One 7, e40443
20. Almkvist, J., and Karlsson, A. (2004) Galectins as inflammatory mediators. Glycoconj J. 19, 575-581
21. Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., and Kasai, K. (1994) Galectins: a family of animal β-galactoside-binding lectins. Cell 76, 597-598
22. Camby, I., Le Mercier, M., Lefranc, F., and Kiss, R. (2006) Galectin-1: a small protein with major functions. Glycobiology 16, 137R-157R
23. Elola, M. T., Wolfenstein-Todel, C., Troncoso, M. F., Vasta, G. R., and Rabinovich, G. A. (2007) Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol. Life Sci. 64, 1679-1700
24. Rabinovich, G. A., and Ilarregui, J. M. (2009) Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol. Rev. 230, 144-159
25. Thijssen, V. L., Postel, R., Brandwijk, R. J., Dings, R. P., Nesmelova, I., Satijn, S., Verhofstad, N., Nakabeppu, Y., Baum, L. G., Bakkers, J., Mayo, K. H., Poirier, F., and Griffioen, A. W. (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. U.S.A. 103, 15975-15980
26. Chan, B., Sinha, S., Cho, D., Ramchandran, R., and Sukhatme, V. P. (2005) Critical roles of CD146 in zebrafish vascular development. Dev. Dyn 232, 232-244
27. Yan, X., Lin, Y., Yang, D., Shen, Y., Yuan, M., Zhang, Z., Li, P., Xia, H., Li, L., Luo, D., Liu, Q., Mann, K., and Bader, B. L. (2003) A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102, 184-191
28. Braeuer, R. R., Shoshan, E., Kamiya, T., and Bar-Eli, M. (2012) The sweet and bitter sides of galectins in melanoma progression. Pigment Cell Melanoma Res. 25, 592-601
29. Cedeno-Laurent, F., Opperman, M. J., Barthel, S. R., Hays, D., Schatton, T., Zhan, Q., He, X., Matta, K. L., Supko, J. G., Frank, M. H., Murphy, G. F., and Dimitroff, C. J. (2012) Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity. J Invest Dermatol 132, 410-420
30. Yang, H., Wang, S., Liu, Z., Wu, M. H., McAlpine, B., Ansel, J., Armstrong, C., and Wu, G. (2001) Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability. Gene 265, 133-145
31. Fischer, I., Schulze, S., Kuhn, C., Friese, K., Walzel, H., Markert, U. R., and Jeschke, U. (2009) Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo. Placenta 30, 1078-1082
32. Hsieh, S. H., Ying, N. W., Wu, M. H., Chiang, W. F., Hsu, C. L., Wong, T. Y., Jin, Y. T., Hong, T. M., and Chen, Y. L. (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27, 3746-3753
33. Jiang, T., Zhuang, J., Duan, H., Luo, Y., Zeng, Q., Fan, K., Yan, H., Lu, D., Ye, Z., Hao, J., Feng, J., Yang, D., and Yan, X. (2012) CD146 is a co-receptor for VEGFR-2 in tumor angiogenesis. Blood 120, 2230-2239
34. Thijssen, V. L., Hulsmans, S., and Griffioen, A. W. (2008) The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am. J. Pathol. 172, 545-553
35. Brandt, B., Abou-Eladab, E. F., Tiedge, M., and Walzel, H. (2010) Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death. Cell Death Dis. 1, e23
36. Perillo, N. L., Pace, K. E., Seilhamer, J. J., and Baum, L. G. (1995) Apoptosis of T cells mediated by galectin-1. Nature 378, 736-739
37. Ouhtit, A., Gaur, R. L., Abd Elmageed, Z. Y., Fernando, A., Thouta, R., Trappey, A. K., Abdraboh, M. E., El-Sayyad, H. I., Rao, P., and Raj, M. G. (2009) Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim. Biophys. Acta 1795, 130-136
38. Jaffe, E. A., Nachman, R. L., Becker, C. G., and Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756
39. Despoix, N., Walzer, T., Jouve, N., Blot-Chabaud, M., Bardin, N., Paul, P., Lyonnet, L., Vivier, E., Dignat-George, F., and Vély, F. (2008) Mouse CD146/MCAM is a marker of natural killer cell maturation. Eur. J. Immunol. 38, 2855-2864
40. Rossi, B., Espeli, M., Schiff, C., and Gauthier, L. (2006) Clustering of pre-B cell integrins induces galectin-1-dependent pre-B cell receptor relocalization and activation. J. Immunol. 177, 796-803
41. Gauthier, L., Rossi, B., Roux, F., Termine, E., and Schiff, C. (2002) Galectin- 1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc. Natl. Acad. Sci. U.S.A. 99, 13014-13019
42. Cederfur, C., Salomonsson, E., Nilsson, J., Halim, A., Oberg, C. T., Larson, G., Nilsson, U. J., and Leffler, H. (2008) Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology 18, 384-394
43. Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T., Hirashima, M., Urashima, T., Oka, T., Futai, M., Muller, W. E., Yagi, F., and Kasai, K. (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572, 232-254
44. Leppänen, A., Stowell, S., Blixt, O., and Cummings, R. D. (2005) Dimeric galectin-1 binds with high affinity to α2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. J. Biol. Chem. 280, 5549-5562
45. Salomonsson, E., Larumbe, A., Tejler, J., Tullberg, E., Rydberg, H., Sundin, A., Khabut, A., Frejd, T., Lobsanov, Y. D., Rini, J. M., Nilsson, U. J., and Leffler, H. (2010) Monovalent interactions of galectin-1. Biochemistry 49, 9518-9532
46. Stowell, S. R., Cho, M., Feasley, C. L., Arthur, C. M., Song, X., Colucci, J. K., Karmakar, S., Mehta, P., Dias-Baruffi, M., McEver, R. P., and Cummings, R. D. (2009) Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation. J. Biol. Chem. 284, 4989-4999
47. Leffler, H., Carlsson, S., Hedlund, M., Qian, Y., and Poirier, F. (2004) Introduction to galectins. Glycoconj. J. 19, 433-440
48. Adams, L., Scott, G. K., and Weinberg, C. S. (1996) Biphasic modulation of cell growth by recombinant human galectin-1. Biochim. Biophys. Acta 1312, 137-144
49. Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J. M., Toscano, M. A., Bianco, G. A., Isturiz, M. A., and Rabinovich, G. A. (2007)Anovel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J. Immunol. 178, 436-445
50. Levroney, E. L., Aguilar, H. C., Fulcher, J. A., Kohatsu, L., Pace, K. E., Pang, M., Gurney, K. B., Baum, L. G., and Lee, B. (2005) Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J. Immunol. 175, 413-420
51. Stowell, S. R., Arthur, C. M., Mehta, P., Slanina, K. A., Blixt, O., Leffler, H., Smith, D. F., and Cummings, R. D. (2008) Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 283, 10109-10123
52. Burns, J. S., Kristiansen, M., Kristensen, L. P., Larsen, K. H., Nielsen, M. O., Christiansen, H., Nehlin, J., Andersen, J. S., and Kassem, M. (2011) Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction. PLoS One 6, e21888
53. Dings, R. P., Van Laar, E. S., Loren, M., Webber, J., Zhang, Y., Waters, S. J., Macdonald, J. R., and Mayo, K. H. (2010) Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. Bioconjug. Chem. 21, 20-27
54. Ito, K., Scott, S. A., Cutler, S., Dong, L. F., Neuzil, J., Blanchard, H., and Ralph, S. J. (2011) Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis 14, 293-307
55. Sakaguchi, M., Shingo, T., Shimazaki, T., Okano, H. J., Shiwa, M., Ishibashi, S., Oguro, H., Ninomiya, M., Kadoya, T., Horie, H., Shibuya, A., Mizusawa, H., Poirier, F., Nakauchi, H., Sawamoto, K., and Okano, H. (2006) A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 103, 7112-7117
56. Thijssen, V. L., Barkan, B., Shoji, H., Aries, I. M., Mathieu, V., Deltour, L., Hackeng, T. M., Kiss, R., Kloog, Y., Poirier, F., and Griffioen, A. W. (2010) Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res. 70, 6216-6224
57. Vas, V., Fajka-Boja, R., Ion, G., Dudics, V., Monostori, E., and Uher, F. (2005) Biphasic effect of recombinant galectin-1 on the growth and death of early hematopoietic cells. Stem Cells 23, 279-287
58. Blaskó, A., Fajka-Boja, R., Ion, G., and Monostori, E. (2011)Howdoes it act when soluble? Critical evaluation of mechanism of galectin-1 induced T-cell apoptosis. Acta Biol. Hung 62, 106-111
59. Baum, L. G., Seilhamer, J. J., Pang, M., Levine, W. B., Beynon, D., and Berliner, J. A. (1995) Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj J. 12, 63-68
60. Perillo, N. L., Uittenbogaart, C. H., Nguyen, J. T., and Baum, L. G. (1997) Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J. Exp. Med. 185, 1851-1858